Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Description

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Conditions

Stroke

Talk to us

Study Overview

On this page

Study Details

Study overview

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Constraint Induced Movement Therapy for Walking in Individuals Post Stroke

Condition
Stroke
Intervention / Treatment

-

Contacts and Locations

Chicago

Abilitylab, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. age between 21 and 75 years;
  • 2. history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
  • 3. no prior stroke;
  • 4. demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
  • 5. able to stand and walk (\>10 meters) without physical assistance.
  • 1. significant cardiorespiratory/metabolic disease;
  • 2. other neurological or orthopedic injury that impairs locomotion;
  • 3. scores on the Mini Mental Status examination \< 24;
  • 4. stroke of the brainstem or cerebellar lesions;
  • 5. uncontrolled hypertension (systolic \> 200 mm Hg, diastolic \> 110 mm Hg);
  • 6. botox injection within 6 months of starting the study.

Ages Eligible for Study

21 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Shirley Ryan AbilityLab,

Ming Wu, PhD, PRINCIPAL_INVESTIGATOR, Abilitylab

Study Record Dates

2024-10-30